ICON plc (ICLR) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
ICON Announces Executive Leadership Transition
October 20, 2016 4:15 AM EDTMr. Ciaran Murray to transition to Chairman, effective 1st March 2017 Dr. Steve Cutler to be appointed Chief Executive Officer, effective 1st March 2017
DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device... More
ICON Reports Third Quarter 2016 Results
October 20, 2016 4:00 AM EDTHighlights
Net business wins of $510 million; net book to bill of 1.21. Backlog of business grows 11.8% year on year to $4.25 billion. Net revenue increases 6.4% to $420 million in the quarter. Income from operations increases 13.7% to 19.3% of revenue before non-recurring charges. Earnings per share increases 17% to $1.19 before non-recurring charges.DUBLIN--(BUSINESS WIRE)--... More
